Use of Transcutaneous and Percutaneous Ablation for the Treatment of Benign and Malignant Tumors of the Breast

Publication Date: October 1, 2018
Last Updated: March 14, 2022

Recommendations

Indications for cryoablation or percutaneous excision of a fibroadenoma:

a. The lesion must be easily visualized on ultrasound.
b. The diagnosis of fibroadenoma must be confirmed histologically on core biopsy prior to treatment.
c. The diagnosis of fibroadenoma must be concordant with the imaging findings, patient history, and physical exam.
d. Lesions should be less than 4 cm in largest diameter.
6731

Indications for focused ultrasound ablation for the treatment of fibroadenoma:

Focused ultrasound ablation for the treatment of fibroadenoma is currently under investigation in the United States, and is not approved by the FDA for this indication. This technique is considered investigational and should not be performed outside the realm of a clinical trial. There is an ongoing FDA-approved clinical trial for “echotherapy” in the treatment of fibroadenomas.
6731

Indications for percutaneous and/or transcutaneous ablative treatments of malignant tumors of the breast:

Cryoablation is currently approved for treatment of benign and malignant soft tissue tumors by the FDA. Currently, there are no specific technologies that have FDA approval for breast tumors. Participation in registries and clinical trials evaluating the use of these technologies with and without surgical excision of a breast malignancy is advised as early data emerges on their efficacy.
6731

Recommendation Grading

Overview

Title

Use of Transcutaneous and Percutaneous Ablation for the Treatment of Benign and Malignant Tumors of the Breast

Authoring Organization

American Society of Breast Surgeons

Publication Month/Year

October 1, 2018

Last Updated Month/Year

January 23, 2024

Document Type

Consensus

External Publication Status

Published

Country of Publication

US

Document Objectives

To outline current data on transcutaneous and percutaneous ablation methods for treatment of benign and malignant tumors of the breast.

Inclusion Criteria

Female, Male, Adult, Older adult

Health Care Settings

Operating and recovery room, Outpatient, Radiology services

Intended Users

Radiology technologist, clinical researcher, nurse, nurse practitioner, physician, physician assistant

Scope

Management, Treatment

Diseases/Conditions (MeSH)

D001943 - Breast Neoplasms, D018226 - Fibroadenoma

Keywords

fibroadenomas, Tumors of the Breast, Percutaneous Ablation, Transcutaneous Ablation